MFine, a leading digital healthcare startup, has teamed up with oncology research and solutions provider Data Cancer Genetics to launch a new cancer screening feature on its digital platform and app. For the first time, MFine users will be able to book a variety of cancer diagnostic tests from Data's EasyCheck, which will be completely integrated into the app.
For those unfamiliar, EasyCheck is a "non-invasive, radiation-free test for early cancer detection." The technology can check for cancers in various sites, including lungs, esophagus, oral cavity, liver, stomach, gallbladder, kidneys, and pancreas.
"Providing people with an easy and non-invasive way to screen is imperative to make this change and witness a cancer-free India. Partnering with MFine now creates accessibility to a large number of people who can screen themselves [from] the comfort of their homes," said Samara Mahindra, director for new cancer initiatives at Datar Cancer Genetics.
At-Home Cancer Screening Tools
MFine Partners with Datar to Launch New Cancer Screening Feature
Trend Themes
1. At-home Cancer Screening - The partnership between MFine and Datar to launch a new cancer screening feature opens up the possibility of early detection and diagnosis of cancer from the comfort of one's home.
2. Digital Health Platforms - The incorporation of cancer screening tools into the MFine platform highlights the trend of digital health platforms expanding their services to include diagnostic tools.
3. Non-invasive Cancer Detection - The development of non-invasive, radiation-free cancer detection technologies such as EasyCheck is becoming increasingly relevant in the healthcare industry, opening up opportunities for similar innovations.
Industry Implications
1. Healthcare - This partnership demonstrates an opportunity for the healthcare industry to adopt digital tools and incorporate cancer screening and diagnostics into their services.
2. Technology - The trend towards developing non-invasive cancer detection technologies, such as EasyCheck, highlights opportunities for technology companies to innovate in the healthcare industry.
3. Research and Development - Innovation in non-invasive cancer detection technologies presents opportunities for research and development, particularly in the field of oncology and diagnostics.